GKOS
Glaukos Corporation
October 28, 2026 · after-hours
- Rarity
- 3.33
- Peak move
- +18.51%
- Float cap
- $10.0B
Still running — rarity and peak move can only rise from here.
Glaukos is an ophthalmic pharmaceutical and medical technology company developing therapies for glaucoma, corneal disorders and retinal diseases. It sells minimally invasive glaucoma surgery devices such as iStent to ophthalmic surgeons and hospitals, along with iDose TR, a long-duration intracameral drug delivery implant, and Photrexa/Epioxa corneal cross-linking treatments for keratoconus. Its customers are eye-care physicians, ambulatory surgery centers and payers, mainly in the United States with growing international sales.
Where do you see this going?
no votes yetVote to see the split.
What we found
no events · 0 from SEC or newswire · 0 timed with the moveNothing found.We searched SEC filings, the newswires and the open web across the three days around this move and found no public information that explains it.